Katherine Gowan

Immunology and Microbiology · Life Sciences

30h-index4.7kcitations60works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Atherosclerosis and Cardiovascular Diseases(14), melanin and skin pigmentation(13), Lung Cancer Treatments and Mutations(12), RNA modifications and cancer(11), Cardiomyopathy and Myosin Studies(7)

Publications60 total

Supplementary Table 1 from Resistance Mechanisms to Targeted Therapies in <i>ROS1</i><sup>+</sup> and <i>ALK</i><sup>+</sup> Non–small Cell Lung Cancer
2023Open Access
Supplementary Figures 1-5 from Resistance Mechanisms to Targeted Therapies in <i>ROS1</i><sup>+</sup> and <i>ALK</i><sup>+</sup> Non–small Cell Lung Cancer
2023Open Access
Supplementary Table 1 from Resistance Mechanisms to Targeted Therapies in <i>ROS1</i><sup>+</sup> and <i>ALK</i><sup>+</sup> Non–small Cell Lung Cancer
2023Open Access
Supplementary Table 2 from Resistance Mechanisms to Targeted Therapies in <i>ROS1</i><sup>+</sup> and <i>ALK</i><sup>+</sup> Non–small Cell Lung Cancer
2023Open Access
Supplementary Table 2 from Resistance Mechanisms to Targeted Therapies in <i>ROS1</i><sup>+</sup> and <i>ALK</i><sup>+</sup> Non–small Cell Lung Cancer
2023Open Access
Supplementary Table 3 from Resistance Mechanisms to Targeted Therapies in <i>ROS1</i><sup>+</sup> and <i>ALK</i><sup>+</sup> Non–small Cell Lung Cancer
2023Open Access
Data from Resistance Mechanisms to Targeted Therapies in <i>ROS1</i><sup>+</sup> and <i>ALK</i><sup>+</sup> Non–small Cell Lung Cancer
2023Open Access
Supplementary Figures 1-5 from Resistance Mechanisms to Targeted Therapies in <i>ROS1</i><sup>+</sup> and <i>ALK</i><sup>+</sup> Non–small Cell Lung Cancer
2023Open Access
Supplementary Table 3 from Resistance Mechanisms to Targeted Therapies in <i>ROS1</i><sup>+</sup> and <i>ALK</i><sup>+</sup> Non–small Cell Lung Cancer
2023Open Access
Data from Resistance Mechanisms to Targeted Therapies in <i>ROS1</i><sup>+</sup> and <i>ALK</i><sup>+</sup> Non–small Cell Lung Cancer
2023Open Access
In vivo interferon-gamma induced changes in gene expression dramatically alter neutrophil phenotype
PLoS ONE·2022· 19 citedOpen Access
Interferon-Gamma Induced Changes in Gene Expression Dramatically Alter Neutrophil Phenotype
Blood·2018· 1 cited
Pathogenic variants in glutamyl-tRNAGln amidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder
Nature Communications·2018· 53 citedOpen Access
Idiopathic Scoliosis Families Highlight Actin-Based and Microtubule-Based Cellular Projections and Extracellular Matrix in Disease Etiology
G3 Genes Genomes Genetics·2018· 21 citedOpen Access
Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples
Journal of Thoracic Oncology·2018· 162 citedOpen Access
EPEN-16. PATIENT-DERIVED PFA EPENDYMOMA XENOGRAFT MODEL
Neuro-Oncology·2018Open Access
Elucidating the Role of the Maternal Embryonic Leucine Zipper Kinase in Adrenocortical Carcinoma
Endocrinology·2018· 24 citedOpen Access
Resistance Mechanisms to Targeted Therapies in <i>ROS1</i> + and <i>ALK</i> + Non–small Cell Lung Cancer
Clinical Cancer Research·2018· 241 cited
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures
JACC. Clinical electrophysiology·2018· 181 citedOpen Access
Development of new preclinical models to advance adrenocortical carcinoma research
Endocrine Related Cancer·2018· 70 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Pamela R. Fain(20), Richard A. Spritz(15), Kenneth L. Jones(13), Ying Jin(11), Dorothy C. Bennett(9), Sheri L. Riccardi(8), Paulene J. Holland(8), Dara L. Aisner(7), Robert C. Doebele(7), Matthew R.G. Taylor(7), Stanca A. Birlea(6), Caroline E. McCoach(6), Anh T. Le(6), Paul A. Bunn(6), D. Ross Camidge(6), Dobromir Slavov(6), Luisa Mestroni(6), Kenneth L. Jones(6), Christina M. Mailloux(5), Laura Schubert(5)